{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:44:31Z","timestamp":1791420271666,"version":"4.3.3"},"reference-count":46,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1955,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009023","name":"Precursory Research for Embryonic Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009023","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002241","name":"Japan Science and Technology Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1038\/mt.2011.36","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T15:29:17Z","timestamp":1299598157000},"page":"1107-1115","source":"Crossref","is-referenced-by-count":47,"title":["MicroRNA Regulation of Glycoprotein B5R in Oncolytic Vaccinia Virus Reduces Viral Pathogenicity Without Impairing Its Antitumor Efficacy"],"prefix":"10.1016","volume":"19","author":[{"given":"Mina","family":"Hikichi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Kidokoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Haraguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Iba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisatoshi","family":"Shida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2011.36_bib1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1038\/nrc1750","article-title":"Recent progress in the battle between oncolytic viruses and tumours","volume":"5","author":"Parato","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/mt.2011.36_bib2","series-title":"Fields Virology","first-page":"2849","article-title":"Poxviridae: The viruses and their replication","author":"Moss","year":"2001"},{"key":"10.1038\/mt.2011.36_bib3","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S1470-2045(08)70107-4","article-title":"Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial","volume":"9","author":"Park","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1038\/mt.2011.36_bib4","doi-asserted-by":"crossref","first-page":"10038","DOI":"10.1158\/0008-5472.CAN-07-0146","article-title":"Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus","volume":"67","author":"Zhang","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2011.36_bib5","series-title":"Vaccinia Virus as Vectors for Vaccine Antigens","first-page":"421","article-title":"Properties of attenuated mutant of vaccinia virus, LC16m8, derived from Lister strain","author":"Hashizume","year":"1985"},{"key":"10.1038\/mt.2011.36_bib6","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","article-title":"LC16m8: an attenuated smallpox vaccine","volume":"24","author":"Kenner","year":"2006","journal-title":"Vaccine"},{"key":"10.1038\/mt.2011.36_bib7","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jama.2009.289","article-title":"Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8","volume":"301","author":"Saito","year":"2009","journal-title":"JAMA"},{"key":"10.1038\/mt.2011.36_bib8","first-page":"269","article-title":"Report of the National Smallpox Vaccination Research Committee: Study of side effects, complications and their treatments","volume":"3","author":"Yamaguchi","year":"1975","journal-title":"Clin Virol"},{"key":"10.1038\/mt.2011.36_bib9","doi-asserted-by":"crossref","first-page":"11873","DOI":"10.1128\/JVI.79.18.11873-11891.2005","article-title":"An attenuated LC16m8 smallpox vaccine: analysis of full-genome sequence and induction of immune protection","volume":"79","author":"Morikawa","year":"2005","journal-title":"J Virol"},{"key":"10.1038\/mt.2011.36_bib10","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/0042-6822(91)90480-Y","article-title":"Regulation of plaque size and host range by a vaccinia virus gene related to complement system proteins","volume":"181","author":"Takahashi-Nishimaki","year":"1991","journal-title":"Virology"},{"key":"10.1038\/mt.2011.36_bib11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1006\/viro.1993.1302","article-title":"The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence","volume":"194","author":"Engelstad","year":"1993","journal-title":"Virology"},{"key":"10.1038\/mt.2011.36_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1083\/jcb.200104124","article-title":"Vaccinia virus utilizes microtubules for movement to the cell surface","volume":"154","author":"Hollinshead","year":"2001","journal-title":"J Cell Biol"},{"key":"10.1038\/mt.2011.36_bib13","doi-asserted-by":"crossref","first-page":"12266","DOI":"10.1128\/JVI.77.22.12266-12275.2003","article-title":"Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein","volume":"77","author":"Katz","year":"2003","journal-title":"J Virol"},{"key":"10.1038\/mt.2011.36_bib14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1126\/science.1101509","article-title":"SRC mediates a switch from microtubule- to actin-based motility of vaccinia virus","volume":"306","author":"Newsome","year":"2004","journal-title":"Science"},{"key":"10.1038\/mt.2011.36_bib15","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/ncb1101-992","article-title":"Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus","volume":"3","author":"Rietdorf","year":"2001","journal-title":"Nat Cell Biol"},{"key":"10.1038\/mt.2011.36_bib16","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1128\/jvi.68.1.130-147.1994","article-title":"Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network","volume":"68","author":"Schmelz","year":"1994","journal-title":"J Virol"},{"issue":"Pt 12","key":"10.1038\/mt.2011.36_bib17","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J Gen Virol"},{"key":"10.1038\/mt.2011.36_bib18","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1128\/JVI.75.10.4802-4813.2001","article-title":"Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera","volume":"75","author":"Ward","year":"2001","journal-title":"J Virol"},{"key":"10.1038\/mt.2011.36_bib19","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1128\/jvi.67.8.4732-4741.1993","article-title":"Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination","volume":"67","author":"Wolffe","year":"1993","journal-title":"J Virol"},{"key":"10.1038\/mt.2011.36_bib20","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1073\/pnas.0406671102","article-title":"Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8","volume":"102","author":"Kidokoro","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.36_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.4161\/cbt.4.5.1820","article-title":"Viral oncolysis by herpes simplex virus and other viruses","volume":"4","author":"Kuruppu","year":"2005","journal-title":"Cancer Biol Ther"},{"key":"10.1038\/mt.2011.36_bib22","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1038\/sj.onc.1209044","article-title":"Oncolytic adenoviruses - selective retargeting to tumor cells","volume":"24","author":"Mathis","year":"2005","journal-title":"Oncogene"},{"key":"10.1038\/mt.2011.36_bib23","doi-asserted-by":"crossref","first-page":"e1000440","DOI":"10.1371\/journal.ppat.1000440","article-title":"Use of tissue-specific microRNA to control pathology of wild-type adenovirus without attenuation of its ability to kill cancer cells","volume":"5","author":"Cawood","year":"2009","journal-title":"PLoS Pathog"},{"key":"10.1038\/mt.2011.36_bib24","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1158\/1078-0432.CCR-09-0051","article-title":"MicroRNA regulation of oncolytic herpes simplex virus-1 for selective killing of prostate cancer cells","volume":"15","author":"Lee","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.1038\/mt.2011.36_bib25","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/mt.2008.130","article-title":"A let-7 MicroRNA-sensitive vesicular stomatitis virus demonstrates tumor-specific replication","volume":"16","author":"Edge","year":"2008","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.36_bib26","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/nm.1776","article-title":"Engineering microRNA responsiveness to decrease virus pathogenicity","volume":"14","author":"Kelly","year":"2008","journal-title":"Nat Med"},{"key":"10.1038\/mt.2011.36_bib27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1064921","article-title":"Identification of novel genes coding for small expressed RNAs","volume":"294","author":"Lagos-Quintana","year":"2001","journal-title":"Science"},{"key":"10.1038\/mt.2011.36_bib28","doi-asserted-by":"crossref","first-page":"9779","DOI":"10.1073\/pnas.1630797100","article-title":"MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms","volume":"100","author":"Zeng","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.36_bib29","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0960-9822(02)00809-6","article-title":"Identification of tissue-specific microRNAs from mouse","volume":"12","author":"Lagos-Quintana","year":"2002","journal-title":"Curr Biol"},{"key":"10.1038\/mt.2011.36_bib30","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1056\/NEJMp058190","article-title":"MicroRNAs as oncogenes and tumor suppressors","volume":"353","author":"Chen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1038\/mt.2011.36_bib31","doi-asserted-by":"crossref","first-page":"11612","DOI":"10.1158\/0008-5472.CAN-07-5019","article-title":"Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer","volume":"67","author":"Sempere","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2011.36_bib32","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1158\/0008-5472.CAN-06-4607","article-title":"Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma","volume":"67","author":"Gramantieri","year":"2007","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2011.36_bib33","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1158\/0008-5472.CAN-04-0637","article-title":"Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival","volume":"64","author":"Takamizawa","year":"2004","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2011.36_bib34","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"10.1038\/mt.2011.36_bib35","doi-asserted-by":"crossref","first-page":"6698","DOI":"10.1038\/onc.2008.282","article-title":"Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma","volume":"27","author":"M\u00fcller","year":"2008","journal-title":"Oncogene"},{"key":"10.1038\/mt.2011.36_bib36","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/hum.2008.134","article-title":"let-7 MicroRNA transfer in pancreatic cancer-derived cells inhibits in vitro cell proliferation but fails to alter tumor progression","volume":"20","author":"Torrisani","year":"2009","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2011.36_bib37","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.chom.2008.08.003","article-title":"Harnessing endogenous miRNAs to control virus tissue tropism as a strategy for developing attenuated virus vaccines","volume":"4","author":"Barnes","year":"2008","journal-title":"Cell Host Microbe"},{"key":"10.1038\/mt.2011.36_bib38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35040556","article-title":"Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA","volume":"408","author":"Pasquinelli","year":"2000","journal-title":"Nature"},{"key":"10.1038\/mt.2011.36_bib39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.virol.2004.05.004","article-title":"Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin","volume":"325","author":"Bell","year":"2004","journal-title":"Virology"},{"key":"10.1038\/mt.2011.36_bib40","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of Vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"P\u00fctz","year":"2006","journal-title":"Nat Med"},{"key":"10.1038\/mt.2011.36_bib41","doi-asserted-by":"crossref","first-page":"7544","DOI":"10.1073\/pnas.95.13.7544","article-title":"Extracellular enveloped vaccinia virus is resistant to complement because of incorporation of host complement control proteins into its envelope","volume":"95","author":"Vanderplasschen","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.36_bib42","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1158\/0008-5472.CAN-07-6515","article-title":"Enhancing poxvirus oncolytic effects through increased spread and immune evasion","volume":"68","author":"Kirn","year":"2008","journal-title":"Cancer Res"},{"key":"10.1038\/mt.2011.36_bib43","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1038\/nbt1372","article-title":"Endogenous microRNA can be broadly exploited to regulate transgene expression according to tissue, lineage and differentiation state","volume":"25","author":"Brown","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1038\/mt.2011.36_bib44","doi-asserted-by":"crossref","first-page":"e1000820","DOI":"10.1371\/journal.ppat.1000820","article-title":"MicroRNA antagonism of the picornaviral life cycle: alternative mechanisms of interference","volume":"6","author":"Kelly","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1038\/mt.2011.36_bib45","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1093\/nar\/gng127","article-title":"Inducible shRNA expression for application in a prostate cancer mouse model","volume":"31","author":"Czauderna","year":"2003","journal-title":"Nucleic Acids Res"},{"key":"10.1038\/mt.2011.36_bib46","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1093\/nar\/gkp040","article-title":"Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells","volume":"37","author":"Haraguchi","year":"2009","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616319153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616319153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T03:29:18Z","timestamp":1657682958000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616319153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1525001616319153"],"URL":"https:\/\/doi.org\/10.1038\/mt.2011.36","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}